Stanford Hospital and Clinics
Stanford, California 94305-5407
9 studies enrolling now · 96 studies all time
What they study most
Abdominal Aortic Aneurysm, Acute Kidney Injury, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Advanced Renal Cell Carcinoma, Alcohol Withdrawal, Alcohol Withdrawal Syndrome, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Studies at this site
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System — Recruiting now
- Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network — Recruiting now
- 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT — Recruiting now
- SPYRAL GEMINI Pilot Study — Recruiting now
- Augmented Reality/Virtual Reality (AR/VR) for Ultrasound-guided Medical Procedures — Recruiting now
- Limiting AAA With Metformin (LIMIT) Trial — Recruiting now
- SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
- A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib — Completed
- Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors — Running, not enrolling
- Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma — Running, not enrolling
- Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma — Running, not enrolling
- Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) — Completed
- Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence — Running, not enrolling
- Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin. — Starting soon
- Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel — Available (expanded access)
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR — Completed
- Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry — Completed
- Stanford-Lucidify EEG Delirium Study — Starting soon
- SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study — Completed
- Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia — Completed
- A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
- Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis — Withdrawn before enrolling
- SPYRAL DYSTAL Renal Denervation Global Clinical Study — Completed
- TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) — Completed
- Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors — Stopped early
- A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS — Status unconfirmed
- Varenicline In-Patient Study — Completed
- Absorb IV Randomized Controlled Trial — Completed
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
- ABSORB III Randomized Controlled Trial (RCT) — Completed
- Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) — Completed
- Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) — Completed
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) — Stopped early
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) — Completed
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) — Completed
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) — Completed
- Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) — Completed
- Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) — Completed
- Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN) — Completed
- Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma — Stopped early
- Impact of Unapproved Drug Initiative on Colchicine Use — Completed
- Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants — Completed
- Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study — Completed
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) — Completed
- Double Cord Versus Haploidentical (BMT CTN 1101) — Completed
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer — Stopped early
- Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) — Completed